SPDR® S&P Pharmaceuticals ETF company info

What does SPDR® S&P Pharmaceuticals ETF do?
SPDR® S&P Pharmaceuticals ETF (NYSEARCA:XPH) is a distinctive exchange-traded fund that focuses on the pharmaceuticals sector. It aims to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index. The ETF covers a diverse range of companies within the pharmaceutical industry, including those involved in the research, development, production, and marketing of pharmaceuticals and drugs of all types. The fund's projects and objectives are centered around capturing the dynamics of the pharmaceutical sector, providing investors exposure to this vital industry through a single investment. By tracking the S&P Pharmaceuticals Select Industry Index, SPDR® S&P Pharmaceuticals aims to offer a comprehensive representation of the pharmaceutical market. This ETF is designed for investors looking to tap into the growth potential of the pharmaceutical industry while spreading out their risk across multiple companies within this sector.
SPDR® S&P Pharmaceuticals ETF company media
Company Snapshot

Is SPDR® S&P Pharmaceuticals ETF a public or private company?

key
Ownership
Public

How many people does SPDR® S&P Pharmaceuticals ETF employ?

people
Employees
2,307

What sector is SPDR® S&P Pharmaceuticals ETF in?

pie chart
Sector
ETF

Where is the head office for SPDR® S&P Pharmaceuticals ETF?

location pin
Head Office
Boston, United States

What year was SPDR® S&P Pharmaceuticals ETF founded?

founded flag
Year Founded
2006
What does SPDR® S&P Pharmaceuticals ETF specialise in?
/Exchange Traded Fund /Pharmaceutical Investments /Diversified Portfolio /Market Index Tracking /Equity Holdings /Risk Management

What are the products and/or services of SPDR® S&P Pharmaceuticals ETF?

Overview of SPDR® S&P Pharmaceuticals ETF offerings
Exposure to U.S. Pharmaceutical Companies: XPH invests in a basket of stocks of U.S. pharmaceutical companies. This provides investors with indirect exposure to the performance of these companies and the overall health of the pharmaceutical industry.
Diversification Within Pharmaceuticals: By holding a basket of companies from various subsectors within pharmaceuticals, XPH offers diversification within the industry. This helps reduce concentration risk on any single company's performance.
Potential for Capital Appreciation: The value of XPH can potentially grow over time if the underlying pharmaceutical companies' stock prices increase. This could be driven by factors like successful drug development, mergers and acquisitions, or overall market sentiment towards the pharmaceutical industry.